ApicHope Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
ApicHope Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 76%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.
Key information
76.0%
Debt to equity ratio
CN¥1.70b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥664.23m |
| Equity | CN¥2.23b |
| Total liabilities | CN¥2.34b |
| Total assets | CN¥4.57b |
Recent financial health updates
Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27
ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Recent updates
Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 30%
Dec 06Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 38%
Oct 09Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year
May 27ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings
May 03Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates
May 02ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings
Feb 27Financial Position Analysis
Short Term Liabilities: 300723's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300723's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥870.7M).
Debt to Equity History and Analysis
Debt Level: 300723's net debt to equity ratio (46.3%) is considered high.
Reducing Debt: 300723's debt to equity ratio has increased from 6% to 76% over the past 5 years.
Debt Coverage: 300723's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 300723's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 17:51 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ApicHope Pharmaceutical Co., Ltd is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kehan Meng | Haitong International Research Limited |
| Wen Dai | Huatai Research |
| Jiaxi Xu | Industrial Securities Co. Ltd. |